Previous Article | Next Article ![]()
Journal of Clinical Microbiology, January 2000, p. 55-60, Vol. 38, No. 1
Department of Biotechnology, KTH, Royal
Institute of Technology,1 and Department
of Bacteriology, Swedish Institute for Infectious Disease
Control,2 Stockholm, Sweden
Received 13 May 1999/Returned for modification 21 July
1999/Accepted 27 September 1999
The pertussis toxin (PT) promoter region is a frequently used
target for DNA-based diagnosis of pertussis and parapertussis infections. The reported polymorphism in this region has also allowed
discrimination of species in mixtures with several
Bordetella species by their specific PCR amplicon
restriction patterns. In the present study, we investigated the degree
of polymorphism in order to confirm the reliability of the assay. Five
different sequence types of the amplified 239- or 249-bp region were
found among the 33 Bordetella pertussis, B. parapertussis, and B. bronchiseptica American Type
Culture Collection reference strains and patient isolates analyzed.
According to the sequences that were obtained and according to the PT
promoter sequences already available in the databases, restriction
enzyme analysis with TaqI, BglI, and HaeII, which gave four different patterns, can be performed
to reliably identify B. pertussis, B. parapertussis, and B. bronchiseptica.
0095-1137/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Polymorphism in the Pertussis Toxin Promoter Region
Affecting the DNA-Based Diagnosis of Bordetella
Infection
*
Corresponding author. Mailing address: Department of
Biotechnology, KTH, Royal Institute of Technology, Teknikringen 30, 100 44 Stockholm, Sweden. Phone: 46-8-790 87 58. Fax: 46-8-24 54 52. E-mail: joakim.lundeberg{at}biochem.kth.se.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|